This study investigates metastatic pancreatic adenocarcinoma. It explores the use of an investigational medication in combination with other treatments to evaluate its effects.
The purpose of this study is to evaluate the safety and effectiveness of the investigational medication when used with existing treatments. This study investigates determining the best dosage and understanding how well the combination works.
- Who can participate: Adults 18 years and older with stage IV pancreatic adenocarcinoma may participate. Participants should meet specific health criteria, including adequate organ function and performance status.
- Study details: Participants will receive an investigational medication along with other treatments.